ADAR1 Capital Management »

Abivax SA F shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $215k 15k 14.30

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Abivax SA F

Dr. Jeffrey R. Jay, M.D.
Cormorant Asset Management
Blackstone Group
Commodore Capital
Franklin Resources
VR Adviser
Nantahala Capital Management
Henderson Group
Samsara BioCapital
Saturn V Capital Management
Morgan Stanley
Citadel Advisors
Adage Capital Partners GP
Point72 Asset Management
Rosalind Advisors

View all funds holding Abivax SA F